SCHEMBL2235099

SCHEMBL2235099

CC(=O)C[C]=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8627389 0.69
SCHEMBL25786 0.69
SCHEMBL618275 0.69
SCHEMBL409162 0.69
SCHEMBL8578484 0.69
SCHEMBL27674882 0.67
SCHEMBL86002 0.67
SCHEMBL1259537 0.67
SCHEMBL28489961 0.67
SCHEMBL11853677 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896404-A1 PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP Nabriva Therapeutics Forschungs GmbH (AT) 2008-03-12 EP claimed
WO-2007000004-A1 PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP NABRIVA THERAPEUTICS FORSCHUNGS GMBH (AT) 2007-01-04 WO claimed
EP-1073428-B1 DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES CHOONGWAE PHARMA CO LTD (KR) 2004-10-27 EP claimed
EP-1073428-A1 DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES Choongwae Pharma Co., Ltd. (KR) 2001-02-07 EP claimed
WO-1999055318-A1 DIHYDROXYPHENYL DERIVATIVES FOR HEPATOPROTECTION AND TREATMENT OF LIVER DISEASES CHOONGWAE PHARM. CO., LTD. (KR) 1999-11-04 WO claimed
US-4719231-A 3-[N-(mercaptoacyl)]amino-4-arylbutanoic acid derivatives and an analgesic agent comprising the same ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1988-01-12 US claimed
US-9375397-B2 Composition comprising gas-filled microcapsules for ultrasound mediated delivery BRACCO SUISSE S.A. (CH) 2016-06-28 US disclosed
US-20110208115-A1 Composition Comprising Gas-Filled Microcapsules For Ultrasound Mediated Delivery BRACCO RESEARCH S.A. (CH) 2011-08-25 US disclosed
EP-1879558-B1 PHARMACEUTICAL COMPOSITION COMPRISING GAS-FILLED MICROCAPSULES FOR ULTRASOUND MEDIATED DELIVERY BRACCO RESEARCH SA (CH) 2010-06-09 EP disclosed
US-20090041833-A1 Composition comprising gas-filled microcapsules for ultrasound mediated delivery BRACCO RESEARCH S.A. (CH) 2009-02-12 US disclosed
EP-1587523-A4 MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BRACCO INT BV (NL) 2008-10-22 EP disclosed
EP-1896404-A1 PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP Nabriva Therapeutics Forschungs GmbH (AT) 2008-03-12 EP disclosed
EP-1879558-A1 PHARMACEUTICAL COMPOSITION COMPRISING GAS-FILLED MICROCAPSULES FOR ULTRASOUND MEDIATED DELIVERY BRACCO RESEARCH S.A. (CH) 2008-01-23 EP disclosed
US-5290807-A Antiinflammatory agents CHILDREN'S MEDICAL CENTER CORPORATION (US) 1994-03-01 US disclosed
US-5180738-A Angiogenesis Inhibitors TAKEDA CHEMICAL INDUSTRIES (JP) 1993-01-19 US disclosed
US-5166172-A Angiogenesis inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-11-24 US disclosed
US-5164410-A Fumagillol derivatives and pharmaceutical compositions thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-11-17 US disclosed
EP-0359036-A1 Fumagillol derivatives Takeda Chemical Industries, Ltd. (JP) 1990-03-21 EP disclosed
EP-0357061-A1 Angiogenesis inhibitory agent Takeda Chemical Industries, Ltd. (JP) 1990-03-07 EP disclosed
US-4719231-A 3-[N-(mercaptoacyl)]amino-4-arylbutanoic acid derivatives and an analgesic agent comprising the same ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1988-01-12 US disclosed